Accepted for Publication: August 28, 2013.
Published Online: December 18, 2013. doi:10.1001/jamadermatol.2013.7919.
Study concept and design: Park, Tahan, Kim.
Acquisition of data: All authors.
Analysis and interpretation of data: Park, Tahan, Flaherty, Kim.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: Park, Tahan, Flaherty, Kim.
Statistical analysis: Kim.
Administrative, technical, or material support: Tahan, Flaherty, Kim.
Study supervision: Kim.
Conflict of Interest Disclosures: Drs Kim and Flaherty have served as consultants to Roche. Dr Flaherty has served as a consultant to GlaxoSmithKline. No other disclosures are reported.
Funding/Support:Roche and GlaxoSmithKline funded the underlying clinical trials in which the patients in this report participated. Dr Kim was supported by the Kevin Reagan Memorial Fund and the Eleanor and Miles Shore/Beth Israel Deaconess Medical Center Department of Dermatology Fellowship.
Role of the Sponsor: Roche and GlaxoSmithKline had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Lauren Kovach, BA, Department of Dermatology, Beth Israel Deaconess Medical Center, provided administrative assistance. She was not compensated for her contribution.